Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction
Authors:
- 1 June 2012
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 107 (06) , 1092-1099
Abstract
We assessed whether abnormality of haemostasis measured by a newly developed global method is associated with risk of a first myocardial infarction (MI). The global markers Coagulation activation profile (Cp), Fibrinolysis activation profile (Fp) and sum of fibrin optical density over time (Fibrin OD- sum) were determined in plasma from 800 MI cases and 1,123 controls included in the Stockholm Heart Epidemiology Program. Clot lysis time (CLT) was also determined based on raw data of fibrin OD from the global assay. Odds ratios (OR) of MI with 95% confidence intervals (CI) were calculated using logistic regression. A Fp value 90th percentile value in controls) the adjusted OR of MI was 2.62 (95% CI 1.87–3.66) and for a high Fibrin OD-sum value (>90th percentile in controls) it was 1.86 (95% CI 1.37–2.53). A high Cp value was not significantly associated with MI. In conclusion, we found that abnormal haemostasis in platelet-poor plasma, reflected either as an attenuated fibrinolytic capacity or the resulting increase of fibrin formation, was associated with increased MI risk.Keywords
This publication has 22 references indexed in Scilit:
- Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older menJournal of Thrombosis and Haemostasis, 2009
- A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasmaThrombosis and Haemostasis, 2007
- A Simple and Rapid Laboratory Method for Determination of Haemostasis Potential in PlasmaThrombosis Research, 2001
- Family History of Coronary Heart Disease, a Strong Risk Factor for Myocardial Infarction Interacting with Other Cardiovascular Risk Factors: Results from the Stockholm Heart Epidemiology Program (SHEEP)Epidemiology, 2001
- Plasma Levels of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex and von Willebrand Factor Are Significant Risk Markers for Recurrent Myocardial Infarction in the Stockholm Heart Epidemiology Program (SHEEP) StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the S heep studyJournal of Internal Medicine, 1999
- Prospective Study of Hemostatic Factors and Incidence of Coronary Heart DiseaseCirculation, 1997
- Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysisBlood, 1995
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980